Lataa...
Autotaxin in Pathophysiology and Pulmonary Fibrosis
Lysophospholipid signaling is emerging as a druggable regulator of pathophysiological responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in idiopathic pulmonary fibrosis (IPF) patients. In this review, we focus on ectonucleotide pyrophosphatase-phosphodiesterase...
Tallennettuna:
| Julkaisussa: | Front Med (Lausanne) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6008954/ https://ncbi.nlm.nih.gov/pubmed/29951481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00180 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|